Skip to content


14 - 16 Okt 2021

35th EACTS

CytoSorbents Symposium 1
14. Oktober, 2021 | 12:45-14:00 CET | Raum 113

Hemoadsorption with CytoSorb in various cardiac surgery indications
Vorsitz:  Christian Hagl, München, Deutschland

  • Removal of Ticagrelor to reduce bleeding complications and costs in high urgency operations
    Stephan Geidel, Hamburg, Deutschland
  • The challenge to master refractory vasoplegic shock
    Nandor Marczin, Harefield, UK
  • Feasibility and safety aspects in heart transplantation
    Endre Németh, Budapest, Ungarn
  • ECMO in combination with hemoadsorption in cardiac surgery patients
    Leonardo Gottin, Verona, Italien


download Program

CytoSorbents Symposium 2
15. Oktober, 2021 | 12:45-14:00 CET | Raum 113

Role of CytoSorb hemoadsorption therapy in endocarditis patients
Vorsitz: Carlos Mestres, Zürich, Schweiz

  • Intraoperative use – First results from the REMOVE trial
    Torsten Doenst, Jena, Deutschland
  • Intraoperative and postoperative use – Which patients benefit most?
    Daniel Wendt, Essen, Deutschland
  • Can hemoadsorption reduce the amount of postoperative vasoactive drugs?
    Anna Holmén, Gothenburg, Schweden
  • We need an individualized approach – Results of a large retrospective study
    Jurij Kalisnik, Nürnberg, Deutschland


download Program

Jetzt registrieren

Angemeldete Teilnehmer können das Symposium auch im Livestream auf der EACTS-Website verfolgen!



More Info

Congress Website
This site is registered on as a development site. Switch to a production site key to remove this banner.